OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 26.00
+1.05 (4.21%)
Sep 8, 2026, 1:30 PM CST
OBI Pharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 313.26 | 759.33 | 1,732 | 899.28 | 4,741 | 2,512 |
Short-Term Investments | 183.7 | 427 | 1,399 | 1,883 | 30.71 | 140 |
Trading Asset Securities | - | - | 0.09 | 0.23 | 0.75 | 1.77 |
Cash & Short-Term Investments | 496.96 | 1,186 | 3,131 | 2,782 | 4,773 | 2,654 |
Cash Growth | -74.69% | -62.11% | 12.53% | -41.70% | 79.83% | -28.69% |
Accounts Receivable | 4.57 | 12.71 | 4.2 | 6.48 | 2.04 | 3.47 |
Other Receivables | 262.6 | 307.4 | 246.34 | 225.86 | 26.24 | 19.8 |
Receivables | 267.17 | 320.11 | 250.54 | 232.34 | 28.27 | 23.27 |
Inventory | 18.05 | 18.43 | 27.73 | 25.93 | 21.97 | 9.56 |
Prepaid Expenses | 59.27 | 55.22 | 30.68 | 26.38 | 211.26 | 167.35 |
Other Current Assets | - | - | - | 100.34 | - | - |
Total Current Assets | 841.46 | 1,580 | 3,440 | 3,167 | 5,034 | 2,854 |
Property, Plant & Equipment | 883.68 | 994.29 | 1,165 | 1,249 | 1,176 | 1,149 |
Long-Term Investments | 875.08 | 747.34 | 946.95 | 1,070 | 8.73 | 9.11 |
Goodwill | - | - | - | - | 61.15 | 61.15 |
Other Intangible Assets | 38.68 | 46.86 | 62.84 | 73.18 | 321.29 | 337.14 |
Other Long-Term Assets | 51.05 | 52.69 | 39.03 | 51.64 | 32.9 | 76.21 |
Total Assets | 2,690 | 3,421 | 5,654 | 5,611 | 6,634 | 4,487 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 0.99 | 3.44 | 0.77 | 1.14 | 0.53 |
Accrued Expenses | 14.21 | 92.18 | 251.9 | 65.76 | 112.49 | 177.82 |
Short-Term Debt | 68.41 | 50.35 | 0.41 | 4.31 | 15.71 | - |
Current Portion of Long-Term Debt | 65.54 | 71.87 | 34.09 | 7 | 7 | 7 |
Current Portion of Leases | 50.01 | 54.02 | 55.12 | 49.86 | 40.35 | 52.07 |
Current Income Taxes Payable | 2.72 | 2.46 | 10.39 | 1.58 | 0.56 | 0.34 |
Current Unearned Revenue | 11.43 | 2.29 | 7.78 | 6.29 | 3.16 | - |
Other Current Liabilities | 14.86 | 76.4 | 49.24 | 30.28 | 40.73 | 89.47 |
Total Current Liabilities | 227.18 | 350.56 | 412.37 | 165.84 | 221.14 | 327.22 |
Long-Term Debt | - | 29.46 | 48.22 | 60.06 | 67.07 | 28 |
Long-Term Leases | 262.18 | 309.98 | 366.79 | 425.89 | 163.03 | 205.96 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 46.33 | 54.76 |
Other Long-Term Liabilities | 6.2 | 6.14 | 6.01 | 5.89 | 0 | - |
Total Liabilities | 495.56 | 696.13 | 833.39 | 657.67 | 497.57 | 615.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,316 | 1,316 | 2,632 | 2,294 | 2,294 | 1,993 |
Additional Paid-In Capital | 9,437 | - | - | 7,128 | 6,933 | 3,702 |
Retained Earnings | -9,254 | -8,616 | -7,879 | -5,569 | -4,523 | -2,909 |
Treasury Stock | - | - | -26.53 | -26.53 | -45.99 | -45.99 |
Comprehensive Income & Other | -11.35 | 9,189 | 9,089 | -19.87 | -26.32 | -24.53 |
Total Common Equity | 1,487 | 1,889 | 3,815 | 3,807 | 4,632 | 2,716 |
Minority Interest | 706.9 | 836.58 | 1,006 | 1,147 | 1,504 | 1,155 |
Shareholders' Equity | 2,194 | 2,725 | 4,820 | 4,953 | 6,136 | 3,871 |
Total Liabilities & Equity | 2,690 | 3,421 | 5,654 | 5,611 | 6,634 | 4,487 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 446.14 | 515.68 | 504.63 | 547.11 | 293.15 | 293.03 |
Net Cash (Debt) | 50.82 | 670.65 | 2,626 | 2,235 | 4,479 | 2,361 |
Net Cash Growth | -96.45% | -74.46% | 17.49% | -50.10% | 89.73% | -32.08% |
Net Cash Per Share | 0.39 | 5.10 | 22.48 | 19.52 | 40.33 | 23.73 |
Filing Date Shares Outstanding | 131.58 | 131.58 | 131.48 | 114.62 | 114.55 | 99.47 |
Total Common Shares Outstanding | 131.58 | 131.58 | 131.48 | 114.62 | 114.55 | 99.47 |
Working Capital | 614.28 | 1,230 | 3,027 | 3,001 | 4,813 | 2,527 |
Book Value Per Share | 11.30 | 14.35 | 29.01 | 33.21 | 40.44 | 27.30 |
Tangible Book Value | 1,449 | 1,842 | 3,752 | 3,734 | 4,250 | 2,318 |
Tangible Book Value Per Share | 11.01 | 14.00 | 28.53 | 32.57 | 37.10 | 23.30 |
Land | - | - | - | - | 87.51 | 87.51 |
Buildings | 344.49 | 344.49 | 344.49 | 343.2 | 370.02 | 329.28 |
Machinery | 1,063 | 1,061 | 1,080 | 1,022 | 1,054 | 671.26 |
Construction In Progress | - | 1.65 | 10.07 | 66.46 | 35.74 | 368.45 |
Leasehold Improvements | 266.18 | 265.97 | 276.85 | 181.24 | 184.06 | 65.85 |